Teligent Pre-Tax Profit Margin 2010-2021 | TLGT

Teligent pre-tax profit margin from 2010 to 2021. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Teligent Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2021-06-30 $0.05B $-0.09B -193.48%
2021-03-31 $0.05B $-0.09B -180.00%
2020-12-31 $0.05B $-0.12B -264.44%
2020-09-30 $0.05B $-0.05B -90.20%
2020-06-30 $0.06B $-0.05B -96.36%
2020-03-31 $0.06B $-0.04B -72.88%
2019-12-31 $0.07B $-0.03B -38.46%
2019-09-30 $0.07B $-0.03B -51.52%
2019-06-30 $0.07B $-0.03B -46.97%
2019-03-31 $0.06B $-0.04B -62.50%
2018-12-31 $0.07B $-0.04B -54.55%
2018-09-30 $0.06B $-0.03B -46.67%
2018-06-30 $0.05B $-0.03B -62.26%
2018-03-31 $0.06B $-0.02B -38.18%
2017-12-31 $0.06B $-0.02B -25.00%
2017-09-30 $0.06B $-0.01B -22.22%
2017-06-30 $0.07B $-0.01B -11.76%
2017-03-31 $0.07B $-0.01B -14.93%
2016-12-31 $0.06B $-0.01B -19.05%
2016-09-30 $0.06B $-0.01B -20.97%
2016-06-30 $0.06B $-0.01B -22.41%
2016-03-31 $0.05B $-0.00B -2.00%
2015-12-31 $0.05B $0.01B 15.56%
2015-09-30 $0.05B $0.02B 41.30%
2015-06-30 $0.04B $0.02B 53.66%
2015-03-31 $0.04B $0.01B 34.21%
2014-12-31 $0.03B $0.01B 17.65%
2014-09-30 $0.03B 0 0.00%
2014-06-30 $0.02B 0 0.00%
2014-03-31 $0.02B 0 0.00%
2013-12-31 $0.02B 0 0.00%
2013-09-30 $0.01B $-0.00B -7.14%
2013-06-30 $0.01B $-0.00B -16.67%
2013-03-31 $0.01B $-0.00B -30.00%
2012-12-31 $0.01B $-0.00B -50.00%
2012-09-30 $0.01B $-0.00B -50.00%
2012-06-30 $0.01B $-0.00B -37.50%
2012-03-31 $0.01B $-0.00B -37.50%
2011-12-31 $0.01B $-0.00B -37.50%
2011-09-30 $0.01B $-0.00B -37.50%
2011-06-30 $0.01B $-0.00B -50.00%
2011-03-31 $0.01B $-0.00B -50.00%
2010-12-31 $0.01B $-0.00B -57.14%
2010-09-30 $0.01B $-0.00B -66.67%
2010-06-30 $0.01B $-0.00B -80.00%
2010-03-31 $0.00B $-0.01B -125.00%
2009-12-31 $0.00B $-0.01B -125.00%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.597B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00